Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mesoblast
Pharma
Mesoblast scores FDA committee's backing for cell therapy
An FDA advisory committee voted 9-1 to recommend Mesoblast's Ryoncil for approval despite some worries over its data and manufacturing.
Kyle Blankenship
Aug 14, 2020 8:36am
Mesoblast takes FDA flack over cell therapy data: documents
Aug 12, 2020 8:29am
Mesoblast reaches milestone on Temcell with Japan partner JCR
Sep 21, 2015 3:46am